LXEO Earnings Date: Dec 14, 2026 (Estimated) — Lexeo Therapeutics, Inc. Common Stock
XNAS · Healthcare · Biotechnology
Updated
When is LXEO's next earnings date?
Lexeo Therapeutics, Inc. Common Stock (LXEO) is expected to report Q3 2026 earnings on Monday, December 14, 2026 at 7:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.32.
How did LXEO do in its last earnings report?
In its most recent report on Aug 12, 2026 (Q2 2026), Lexeo Therapeutics, Inc. Common Stock posted EPS of -$0.30 versus the -$0.29 estimate, a miss of 7.1%. Revenue was $0. The stock's 1-day post-earnings move was +1.9%.
How much does LXEO stock move after earnings?
LXEO beat EPS estimates in 5 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 3.5% (up or down) in the day after earnings.
About Lexeo Therapeutics, Inc. Common Stock
Lexeo Therapeutics Inc is a clinical-stage genetic medicine company engaged in the development of gene therapy candidates targeting the underlying genetic causes of cardiovascular diseases. The company is advancing a portfolio of programs focused on conditions such as Friedreich ataxia, cardiomyopathy, plakophilin-2, or PKP2, and arrhythmogenic cardiomyopathy, with its lead candidates including LX2006 and LX2020. Its therapies utilize AAV-based vectors designed to deliver functional genes to cardiac cells to restore normal function and address high unmet medical needs.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-12 | Q2 2026 | -0.29 | -0.30 | -7.14% | $0 | ❌ Miss | +1.88% | +3.14% | -8.79% |
| 2026-05-11 | Q1 2026 | -0.30 | -0.25 | +16.67% | $0 | ✅ Beat | +4.97% | -12.69% | -27.27% |
| 2026-03-30 | Q4 2025 | -0.31 | -0.27 | +12.90% | $0 | ✅ Beat | +8.92% | +19.73% | +7.78% |
| 2025-11-05 | Q3 2025 | -0.46 | -0.33 | +28.26% | $0 | ✅ Beat | -1.80% | +9.22% | +8.86% |
| 2025-08-14 | Q2 2025 | -0.65 | -0.60 | +7.69% | $0 | ✅ Beat | +1.48% | +1.69% | +9.75% |
| 2024-11-13 | Q3 2024 | -0.68 | -0.89 | -30.88% | $0 | ❌ Miss | -0.65% | -21.72% | -7.28% |
| 2024-08-12 | Q2 2024 | -0.79 | -0.64 | +18.99% | $0 | ✅ Beat | +4.17% | +6.17% | -10.00% |
| 2024-03-11 | Q4 2024 | -0.73 | -0.86 | -17.81% | $0 | ❌ Miss | -4.23% | +2.91% | -11.10% |
Showing last 8 quarters.